Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New taxanes reverse MDR in breast cancer cells

March 31, 1998

New York researchers discover M-47, a DNA-damaging agent with a complex mechanism

March 31, 1998

Novartis presents new antitumor agents at AACR

March 31, 1998

Abbott describes LMW mimetics of TGF-beta

March 31, 1998

Novel camptothecin derivative from Chong Kun Dang presented at AACR

March 31, 1998

Green tea extract shows potent chemopreventive activity in vitro

March 31, 1998

Role of protease inhibitors in chemotherapy explored at AACR meeting

March 31, 1998

Karenitecins: BioNumerik's fourth-generation camptothecin derivatives

March 30, 1998

Extensive preclinical and clinical results presented for Bayer MMP inhibitor

March 30, 1998

Protein farnesyltransferase inhibitors: preclinical studies reported at AACR

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.